Autoimmune Pancreatitis

This is a type of pancreatitis, which is inflammation of the pancreas. In this specific type, the inflammation is caused by the body's immune system attacking the pancreas. It can cause severe pain and problems with digestion.

Condition

What people with Autoimmune Pancreatitis report

Every report comes from a Lived member, sent anonymously.

Have you tried Prednisone for Autoimmune Pancreatitis?

NameHow it went

About Autoimmune Pancreatitis

What It Is

Autoimmune pancreatitis (AIP) is a rare, long-lasting form of pancreatitis in which the immune system inflames the pancreas, the gland behind the stomach that makes digestive enzymes and the hormone insulin. The inflamed pancreas often swells, and nearby ducts, including the bile duct that drains the liver, can narrow. The most common sign is jaundice (yellowing of the skin and whites of the eyes) that often comes without much pain. Others notice mild abdominal discomfort or weight loss, and some have no symptoms at all. AIP matters for two reasons. On scans it can look very much like pancreatic cancer, yet it is treated with medicine rather than surgery. And over time the inflammation and scarring can reduce the pancreas's ability to digest food and control blood sugar. There are two main types. Type 1 is the pancreatic part of IgG4-related disease, a body-wide condition named after an antibody called immunoglobulin G4. It mostly affects men over 60 and often involves other organs, such as the bile ducts, kidneys and salivary glands. Type 2 (also called idiopathic duct-centric pancreatitis) affects younger adults of either sex, stays in the pancreas and is linked to inflammatory bowel disease, especially ulcerative colitis. A third, drug-related form can occur in people receiving immune checkpoint inhibitors, a type of cancer immunotherapy.

Causes & Risk Factors

AIP is an immune-mediated disease, but researchers do not yet know why the immune system turns on the pancreas. Unlike most chronic pancreatitis, it is not linked to heavy drinking. The risk pattern differs by type. Type 1 is most common in older men and is part of a wider IgG4-related process that can affect several organs at once. Type 2 often appears in people who already have ulcerative colitis or another inflammatory bowel disease, usually a few years after the bowel diagnosis. The drug-related form follows treatment with checkpoint inhibitors, typically within a few months of starting them, because these medicines release the brakes on the immune system to fight cancer and can inflame healthy organs too.

How It's Diagnosed

No single test confirms AIP. Because it can closely mimic pancreatic cancer, the first goal of an evaluation is to tell the two apart safely, and a specialist team usually pieces together several kinds of evidence. Imaging with CT or MRI is central. In type 1, the pancreas often looks evenly swollen (sometimes described as sausage-shaped) with a thin rim around it, a pattern that points away from cancer. A blood test for IgG4 helps with type 1: a level above roughly 135 to 140 mg/dL supports the diagnosis, but a raised level alone does not prove it, and levels are usually normal in type 2. Scans and blood tests can also look for IgG4-related changes in other organs, such as the bile ducts or kidneys. When the picture is still unclear, a small tissue sample taken through an endoscope (a thin camera passed through the mouth into the stomach) can show the typical inflammation under the microscope. In some cases, a clear improvement after a short course of steroids also supports the diagnosis, but this is used only once cancer has been carefully considered.

Treatment Options

Treatment aims to settle the inflammation, relieve blockages such as jaundice and protect the pancreas and other organs from lasting damage. Treatment is generally recommended when AIP causes symptoms such as jaundice, pain or other organ involvement. Some people without symptoms are monitored instead, and a minority improve on their own. Corticosteroids, most often prednisone, are the first-line treatment for types 1 and 2. They work quickly, and most people go into remission, meaning symptoms resolve and blood tests and scans improve. The dose starts higher for several weeks and is then tapered over a few months. Longer courses carry the familiar steroid trade-offs, and they can push blood sugar higher, which matters because many people with AIP already have or develop diabetes. Because type 1 often comes back, some people stay on a low maintenance dose of steroid for months or years, which lowers the chance of relapse. For relapses or when steroids are poorly tolerated, rituximab (Rituxan), an antibody medicine that removes the immune cells that make antibodies and is also used for rheumatoid arthritis and some lymphomas, is a common second option. Immune-suppressing drugs such as azathioprine or mycophenolate are sometimes added to reduce steroid needs, but they do not work well on their own. For type 2, treating the related bowel disease is part of the plan. The checkpoint inhibitor-related form is handled differently: recognizing it and pausing or stopping the cancer drug, in discussion with the oncologist, matter most, and steroids have not clearly helped. If the pancreas stops producing enough digestive enzymes, enzyme capsules taken with meals can ease fatty, loose stools and help with weight.

What to Expect

Most people respond well to the first round of treatment, often within weeks. The longer-term picture depends on the type. Type 2 relapses less often. Type 1 returns in roughly a third of people or more, usually in the pancreas or bile ducts, so it is best thought of as a condition to watch over years rather than a one-time illness. Follow-up typically includes periodic blood tests (liver tests, IgG4 levels and blood sugar) and repeat imaging, with closer checks while steroids are being tapered. People with type 1 may also be monitored for IgG4-related disease in other organs. The pancreas can lose function over time. Diabetes is common in AIP, and steroid treatment improves blood sugar in many people but can make it harder to control in others, especially older adults. Some people develop exocrine insufficiency, meaning the pancreas no longer makes enough enzymes to digest fat, which shows up as oily or loose stools and weight loss and is managed with enzyme replacement.

When to Seek Help

See a clinician if you notice yellowing of the skin or eyes, especially without pain, or unexplained weight loss; these need prompt assessment because they can signal a blocked bile duct, whatever the cause. If you have already been treated for AIP, contact your care team promptly if jaundice returns or symptoms come back as steroids are tapered, since that can be a relapse. Seek same-day medical care for severe pain in the upper abdomen with nausea or vomiting, which can mean an attack of acute pancreatitis. While taking steroids or other immune-suppressing medicine, contact your care team promptly about a fever, since these medicines raise the risk of infection.

Questions to Ask Your Doctor

  1. 1.How sure are we that this is autoimmune pancreatitis and not cancer, and what would change that view?
  2. 2.Which type do I have, and do any other organs seem to be involved?
  3. 3.How long will I take steroids, and what is the plan if the disease comes back as the dose is lowered?
  4. 4.How will we check my blood sugar and digestion over time, and when would enzyme capsules make sense?
  5. 5.How often will I need blood tests and scans once I am in remission?

Last reviewed • Oct 2026

Educational content, not medical advice.